{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:42:36Z","timestamp":1791250956687,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00417-024-06451-8","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:02:17Z","timestamp":1710835337000},"page":"2569-2577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Real-time monitoring of riboflavin concentration using different clinically available ophthalmic formulations for epi-off and epi-on corneal cross-linking"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-7102","authenticated-orcid":false,"given":"Marco","family":"Lombardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Massimo","family":"Bernava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Mencucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Fruschelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-967X","authenticated-orcid":false,"given":"Giuseppe","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"3","key":"6451_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/ICO.0000000000000723","volume":"35","author":"Z Meiri","year":"2016","unstructured":"Meiri Z, Keren S, Rosenblatt A, Sarig T, Shenhav L, Varssano D (2016) Efficacy of corneal collagen cross-linking for the treatment of keratoconus: a systematic review and meta-analysis. Cornea 35(3):417\u2013428","journal-title":"Cornea"},{"issue":"1","key":"6451_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10792-021-02019-1","volume":"42","author":"S Serrao","year":"2022","unstructured":"Serrao S, Lombardo G, Lombardo M (2022) Adverse events after riboflavin\/UV-A corneal cross-linking: a literature review. Int Ophthalmol 42(1):337\u2013348","journal-title":"Int Ophthalmol"},{"issue":"9","key":"6451_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.ophtha.2017.03.052","volume":"124","author":"Hersh PS, Stulting RD, Muller D, Durrie DS, Rajpal RK, United States Crosslinking Study Group","year":"2017","unstructured":"Hersh PS, Stulting RD, Muller D, Durrie DS, Rajpal RK, United States Crosslinking Study Group (2017) United States multicenter clinical trial of corneal collagen crosslinking for keratoconus treatment. Ophthalmology 124(9):1259\u20131270","journal-title":"Ophthalmology"},{"key":"6451_CR4","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1038\/srep05652","volume":"4","author":"T Chunyu","year":"2014","unstructured":"Chunyu T, Xiujun P, Zhengjun F, Xia Z, Feihu Z (2014) Corneal collagen cross-linking in keratoconus: a systematic review and meta-analysis. Sci Rep 4:5652","journal-title":"Sci Rep"},{"key":"6451_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jcrs.2009.03.035","volume":"35","author":"T Koller","year":"2009","unstructured":"Koller T, Mrochen M, Seiler T (2009) Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 35:1358\u20131362","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"6451_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jcrs.2014.12.013","volume":"41","author":"M Lombardo","year":"2015","unstructured":"Lombardo M, Pucci G, Barberi R, Lombardo G (2015) Interaction of ultraviolet light with the cornea: clinical implications for corneal crosslinking. J Cataract Refract Surg 41(2):446\u2013459","journal-title":"J Cataract Refract Surg"},{"key":"6451_CR7","doi-asserted-by":"publisher","first-page":"624563","DOI":"10.1155\/2013\/624563","volume":"2013","author":"X Tao","year":"2013","unstructured":"Tao X, Yu H, Zhang Y et al (2013) Role of corneal epithelium in riboflavin\/ultraviolet-A mediated corneal cross-linking treatment in rabbit eyes. Biomed Res Int 2013:624563","journal-title":"Biomed Res Int"},{"key":"6451_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/ICL.0b013e3181d0b74b","volume":"2","author":"C Koppen","year":"2010","unstructured":"Koppen C, Gobin L, Tassignon M-J (2010) The absorption characteristics of the human cornea in ultraviolet-A crosslinking. Eye Contact Lens 2:77\u201380","journal-title":"Eye Contact Lens"},{"key":"6451_CR9","doi-asserted-by":"crossref","unstructured":"Lombardo M, Micali N, Villari V et al (2015) Ultraviolet A - visible spectral absorbance of the human cornea after transepithelial soaking with dextran-enriched and dextran-free riboflavin 0.1% ophthalmic solutions. J Cataract Refract Surg 41:2283\u20132290","DOI":"10.1016\/j.jcrs.2015.11.007"},{"key":"6451_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jcrs.2009.01.009","volume":"35","author":"S Baiocchi","year":"2009","unstructured":"Baiocchi S, Mazzotta C, Cerretani D, Caporossi T, Caporossi A (2009) Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg 35:893\u2013899","journal-title":"J Cataract Refract Surg"},{"key":"6451_CR11","doi-asserted-by":"crossref","unstructured":"Ng SM, Ren M, Lindsley KB, Hawkins BS, Kuo IC (2021) Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus. Cochrane Database Syst Rev (3):CD013512","DOI":"10.1002\/14651858.CD013512.pub2"},{"key":"6451_CR12","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1167\/iovs.11-9385","volume":"53","author":"P Kamaev","year":"2012","unstructured":"Kamaev P, Friedman MD, Sherr E, Muller D (2012) Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci 53:2360\u20132367","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6451_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1179\/1351000213Y.0000000076","volume":"19","author":"S Sel","year":"2014","unstructured":"Sel S, Nass N, P\u00f6tzsch S et al (2014) UVA irradiation of riboflavin generates oxygen-dependent hydroxyl radicals. Redox Rep 19:72\u201379","journal-title":"Redox Rep"},{"key":"6451_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1167\/iovs.11-8059","volume":"53","author":"S Schumacher","year":"2012","unstructured":"Schumacher S, Mrochen M, Wernli J, Bueeler M, Seiler T (2012) Optimization model for UV-Riboflavin corneal cross-linking. Invest Ophthalmol Vis Sci 53:762\u2013769","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"6451_CR15","doi-asserted-by":"publisher","first-page":"e0175002","DOI":"10.1371\/journal.pone.0175002","volume":"12","author":"J-T Lin","year":"2017","unstructured":"Lin J-T, Cheng D-C (2017) Modeling the efficacy profiles of UV-light activated corneal collagen crosslinking. PLoS ONE 12(4):e0175002","journal-title":"PLoS ONE"},{"issue":"7","key":"6451_CR16","doi-asserted-by":"publisher","first-page":"e201800028","DOI":"10.1002\/jbio.201800028","volume":"11","author":"G Lombardo","year":"2018","unstructured":"Lombardo G, Villari V, Micali N et al (2018) Non-invasive optical method for real-time assessment of intracorneal riboflavin concentration and efficacy of corneal cross-linking. J Biophotonics 11(7):e201800028","journal-title":"J Biophotonics"},{"issue":"12","key":"6451_CR17","doi-asserted-by":"publisher","first-page":"e202200218","DOI":"10.1002\/jbio.202200218","volume":"15","author":"G Lombardo","year":"2022","unstructured":"Lombardo G, Bernava GM, Serrao S, Lombardo M (2022) Theranostic-guided corneal cross-linking: pre-clinical evidence on a new treatment paradigm for keratoconus. J Biophotonics 15(12):e202200218","journal-title":"J Biophotonics"},{"issue":"6","key":"6451_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/j.jcrs.0000000000001163","volume":"49","author":"G Lombardo","year":"2023","unstructured":"Lombardo G, Bernava GM, Serrao S, Roszkwoska AM, Lombardo M (2023) Predicting corneal cross-linking treatment efficacy with real-time assessment of corneal riboflavin concentration. J Cataract Refract Surg 49(6):635\u2013641","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"6451_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1167\/iovs.15-18651","volume":"57","author":"M Lombardo","year":"2016","unstructured":"Lombardo M, Micali N, Villari V, Serrao S, Lombardo G (2016) All-optical method to assess stromal concentration of riboflavin in conventional and accelerated UV-A irradiation of the human cornea. Invest Opthalmol Vis Sci 57(2):476\u2013483","journal-title":"Invest Opthalmol Vis Sci"},{"key":"6451_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jcrs.2008.11.036","volume":"35","author":"G Wollensak","year":"2009","unstructured":"Wollensak G, Iomdina E (2009) Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg 35:540\u2013546","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"6451_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jcrs.2016.01.040","volume":"42","author":"E Rosenblat","year":"2016","unstructured":"Rosenblat E, Hersh PS (2016) Intraoperative corneal thickness change and clinical outcomes after corneal collagen crosslinking: standard crosslinking versus hypotonic riboflavin. J Cataract Refract Surg 42(4):596\u2013605","journal-title":"J Cataract Refract Surg"},{"issue":"12","key":"6451_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3928\/1081597X-20160920-03","volume":"32","author":"T Ehmke","year":"2016","unstructured":"Ehmke T, Seiler TG, Fischinger I, Ripken T, Heisterkamp A, Frueh BE (2016) Comparison of corneal riboflavin gradients using dextran and HPMC solutions. J Refract Surg 32(12):798\u2013802","journal-title":"J Refract Surg"},{"key":"6451_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcrs.2018.01.010","volume":"44","author":"RS Rubinfeld","year":"2018","unstructured":"Rubinfeld RS, Stulting RD, Gum GG, Talamo JH (2018) Quantitative analysis of corneal stromal riboflavin concentration without epithelial removal. J Cataract Refract Surg 44:237\u2013242","journal-title":"J Cataract Refract Surg"},{"key":"6451_CR24","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1111\/aos.12884","volume":"94","author":"S Hayes","year":"2016","unstructured":"Hayes S, Morgan SR, O\u2019Brart DP, O\u2019Brart N, Meek KM (2016) A study of stromal riboflavin absorption in ex vivo porcine corneas using new and existing delivery protocols for corneal cross-linking. Acta Ophthalmol 94:e109\u2013e117","journal-title":"Acta Ophthalmol"},{"issue":"Suppl 10","key":"6451_CR25","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1097\/ICO.0000000000000547","volume":"34","author":"MF Al Fayez","year":"2015","unstructured":"Al Fayez MF, Alfayez S, Alfayez Y (2015) Transepithelial versus epithelium-off corneal collagen cross-linking for progressive keratoconus: a prospective randomized controlled trial. Cornea 34(Suppl 10):S53-56","journal-title":"Cornea"},{"key":"6451_CR26","doi-asserted-by":"crossref","unstructured":"D\u2019Oria F, Palaz\u00f3n A, Alio JL (2021) Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis. Eye Vis (Lond) 8(1):34","DOI":"10.1186\/s40662-021-00256-0"},{"issue":"4","key":"6451_CR27","doi-asserted-by":"publisher","first-page":"e0195105","DOI":"10.1371\/journal.pone.0195105","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao J, Li M, Tian M, Shen Y, Zhou X (2018) Conventional and transepithelial corneal cross-linking for patients with keratoconus. PLoS ONE 13(4):e0195105","journal-title":"PLoS ONE"},{"key":"6451_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1081\/DDC-120002997","volume":"28","author":"IP Kaur","year":"2002","unstructured":"Kaur IP, Smitha R (2002) Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28:353\u2013369","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"6451_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3109\/02713683.2011.637656","volume":"37","author":"F Raiskup","year":"2012","unstructured":"Raiskup F, Pinelli R, Spoerl E (2012) Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr. Eye Res 37(3):234\u2013238","journal-title":"Curr. Eye Res"},{"key":"6451_CR30","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1167\/iovs.17-22994","volume":"59","author":"NAL O\u2019Brart","year":"2018","unstructured":"O\u2019Brart NAL, O\u2019Brart DPS, Aldahlawi NH, Hayes S, Meek KM (2018) An investigation of the effects of riboflavin concentration on the efficacy of corneal cross-linking using an enzymatic resistance model in porcine corneas. Invest Ophthalmol Vis Sci 59:1058\u20131065","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6451_CR31","doi-asserted-by":"crossref","unstructured":"Franke MAD, Landes T, Seiler TG et al (2021) Corneal riboflavin gradients and UV-absorption characteristics after topical application of riboflavin in concentrations ranging from 0.1 % to 0.5%. Exp Eye Res 213:108842","DOI":"10.1016\/j.exer.2021.108842"},{"key":"6451_CR32","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3928\/1081597X-20100604-01","volume":"27","author":"HP Iseli","year":"2011","unstructured":"Iseli HP, Popp M, Seiler T, Spoerl E, Mrochen M (2011) Laboratory measurement of the absorption coefficient of riboflavin for ultraviolet light (365 nm). J Refract Surg 27:1952\u20132001","journal-title":"J Refract Surg"},{"issue":"4","key":"6451_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00417-019-04595-6","volume":"258","author":"G Lombardo","year":"2020","unstructured":"Lombardo G, Serrao S, Lombardo M (2020) Comparison between standard and transepithelial corneal crosslinking using a theranostic UV-A device. Graefes Arch Clin Exp Ophthalmol 258(4):829\u2013834","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06451-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06451-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T09:05:09Z","timestamp":1721379909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06451-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06451-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Marco Lombardo and Giuseppe Lombardo are co-inventors on issued family patent (IT102019000011985, CN114126650, and US20230131004) related to this work. Marco Lombardo, Giuseppe Lombardo, and Sebastiano Serrao are equity owners in Regensight srl. Mario Fruschelli, Rita Mencucci, and Giuseppe Massimo Bernava have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}